Global Stem Cells Group has announced an agreement to share protocols with Advancells, a pioneer stem cell company that provides a range of safe treatments for various diseases. The alliance will also pave the way for Global Stem Cells Group to expand operations in India.
Global Stem Cells Group, Inc. announced an alliance with India-based stem cells company Advancells.com, to share protocols and expand GSCG operations in the India subcontinent with stem cell training and a new treatment center.
Advancells, a pioneer stem cell company with some of the most advanced protocols in the world, focuses on therapeutic applications of regenerative medicine primarily used in stem cells generated from the patient’s own body. Advancells delivers technologies for safe and effective treatments using their flagship technologies including autologous stem cell therapy from bone marrow and adipose tissue to patients worldwide; Global Stem Cells Group will implement some Advancells technologies in the StemCell Center of worldwide clinics.
Since 2005, Advancells has safely treated thousands of patients for a range of diseases and medical conditions in its various clinics around the globe. Advancells is supported by physicians, stem cell experts and clinical research scientists to continually monitor and improve the effectiveness of its quality management system with excellence and innovation.
“We are pleased to partner with Global Stem Cells Group, to combine our knowledge and expand our ability to bring stem cell medicine to patients worldwide,” says Advancells CEO Vipul Jain. “I am looking forward to a long and productive alliance.”
For more information, visit the Global Stem Cells Group website, email bnovas(AT)stemcellsgroup.com, or call 305-560-5337.
About Advancells:
Advancells is focused on the therapeutic applications of regenerative medicine primarily used in stem cells generated from the patient’s own body. Using technologies like autologous stem cell therapy from bone marrow and adipose tissue, Advancells has been successfully treating patients on a global level since 2005. The company strives to maintain scientific and ethical traditions through Good Manufacturing Practices in accordance with the accepted national and international norms.